no research on ajantpharm yet.
dalal researches scrips that score in the top of the bse 500, and anything a user holds or watches. when a note passes its source checks, it appears here. notes that fail are never shown.
pick history
every time it was listed, and how it went.
never on a list so far.
in the knowledge base
the latest filings and news.
- Ajanta Pharma Share Pricenewsbusiness standard· 15 nov 2026(opens the source in a new tab)
- Ajanta Pharma Share Pricenewsbusiness standard· 12 nov 2026(opens the source in a new tab)
- Aayush Agrawal discloses creation and release of 11.25 lakh equity shares pledgenewsinvestywise· 9 nov 2026(opens the source in a new tab)
- Buy Ajanta Pharma; target of Rs 4250: Prabhudas Lilladhernewsmoneycontrol· 2 nov 2026(opens the source in a new tab)
- Ajanta Pharma Q2 Results: Net profit rises 49% to ₹388 crore, revenue up 33%newscnbc-tv18· 30 oct 2026(opens the source in a new tab)
- Ajanta Pharma Q1 Profit Rises 4% To ₹255 Crore On Strong Growth In Branded Generic Salesnewsthe free press journal· 28 jul 2025(opens the source in a new tab)
- Ajanta Pharma Q1 Results: Profit rises by 18.1% to Rs 245.77 crore, revenue up 12.1% on-yearnewsthe financial express· 30 jul 2024(opens the source in a new tab)
- Ajanta Pharma gets USFDA approval for Topiramate Extended-Release Capsules; declines after climbing over 4%newszee business· 31 aug 2023(opens the source in a new tab)
- Ajanta Pharma hits record high on impressive Q1 nos, 1,250% dividend payoutnewszee business· 28 jul 2023(opens the source in a new tab)
- Ajanta Pharma stock jumps nearly 9% on strong Q1 results; Should you buy, sell or hold Ajanta Pharma shares?newsthe financial express· 28 jul 2023(opens the source in a new tab)
research ideas and things to consider, not personalised investment advice. every statement links to the filing or article it came from; numbers are computed by dalal from exchange data with their dates. ideas can and do lose money: the track record shows every pick, losers included. decide based on your own situation.